FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

63083007: Cyclobenzaprine hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
104859018 Cyclobenzaprine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
802327014 Cyclobenzaprine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
803141000172119 chlorhydrate de cyclobenzaprine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyclobenzaprine hydrochloride Is a Product containing cyclobenzaprine (medicinal product) false Inferred relationship Some
Cyclobenzaprine hydrochloride Is a Cyclobenzaprine (substance) false Inferred relationship Some
Cyclobenzaprine hydrochloride Is a allergène médicamenteux false Inferred relationship Some
Cyclobenzaprine hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Cyclobenzaprine (substance) true Inferred relationship Some
Cyclobenzaprine hydrochloride Is a Centrally acting muscle relaxant (substance) true Inferred relationship Some
Cyclobenzaprine hydrochloride Is a Skeletal muscle relaxant (substance) true Inferred relationship Some
Cyclobenzaprine hydrochloride Is a Organic cyclic compound true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Cyclobenzaprine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some
Cyclobenzaprine hydrochloride 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some
Cyclobenzaprine hydrochloride 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some
Cyclobenzaprine hydrochloride 7.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some
Cyclobenzaprine hydrochloride 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 7.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 7.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 7.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cyclobenzaprine hydrochloride Inferred relationship Some 1
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 15 mg prolonged-release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 15 mg prolonged-release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 30 mg prolonged-release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Cyclobenzaprine hydrochloride Inferred relationship Some 1
Cyclobenzaprine hydrochloride 30 mg prolonged-release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Cyclobenzaprine hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start